Omega-3 Fatty Acids and Breast Cancer: What the Research Says

Omega-3 Fatty Acids and Breast Cancer: What the Research Says- If you’re living with breast cancer, you’ve probably heard that omega-3 fatty acids may help reduce inflammation and support overall health. But what does the science actually say about omega-3s and breast cancer?

This post reviews evidence about how omega-3 fatty acids affect inflammation, treatment response, recurrence risk, side effects, and overall survivorship in breast cancer patients.

I am a long-term survivor of an incurable blood cancer called multiple myeloma. I’ve been supplementing with omega-3 fatty acids, aka fish oil, for years. Though breast cancer and multiple myeloma are very different cancers, I believe that both myeloma and breast cancer survivors benefit from omega-3 fatty acid supplementation.

If you have any questions about nutritional supplementation for breast cancer, scroll down the page, post a question or comment, and I will reply to you ASAP.

thank you,

David Emerson

Cancer Survivor
Cancer Coach
Director PeopleBeatingCancer

What Are Omega-3 Fatty Acids?

Omega-3 fatty acids are essential polyunsaturated fats that the body cannot produce on its own. The three main types are:

EPA (eicosapentaenoic acid)
DHA (docosahexaenoic acid)
ALA (alpha-linolenic acid)

EPA and DHA are found primarily in fatty fish such as salmon, sardines, and mackerel. ALA is found in plant foods like flaxseed, chia seeds, and walnuts.

Omega-3s are known for their anti-inflammatory properties and cardiovascular benefits—but their potential role in cancer care is increasingly being studied.

Omega 3 Fatty Acids and Breast Cancer

Omega-3s and Breast Cancer Risk

Multiple epidemiologic studies suggest that higher dietary intake of marine omega-3s (EPA/DHA) may be associated with a modest reduction in breast cancer risk.

A meta-analysis published in the journal BMJ found that marine omega-3 intake was associated with a small but statistically significant reduction in breast cancer risk.

Reference: https://www.bmj.com/content/346/bmj.f3706

Importantly, plant-based ALA has not shown the same consistent protective association as marine omega-3s.

While omega-3s are not a guarantee against breast cancer, dietary patterns rich in fatty fish appear to correlate with lower incidence in several population studies.

Omega-3s and Tumor Biology

Preclinical research (cell culture and animal studies) suggests omega-3 fatty acids may:

Reduce inflammatory signaling (e.g., NF-κB pathways)
Alter cell membrane composition
Decrease angiogenesis (new blood vessel formation)
Promote apoptosis (programmed cancer cell death)
Improve chemotherapy sensitivity

For example, laboratory research has shown DHA may increase breast cancer cell sensitivity to chemotherapeutic agents.

However, it’s important to emphasize that lab studies do not automatically translate into clinical benefit in humans.

Omega-3s During Breast Cancer Treatment

1. Chemotherapy Tolerance

Some small clinical trials suggest omega-3 supplementation may help:

Reduce chemotherapy-related weight loss
Improve muscle mass
Reduce inflammation
Improve treatment tolerance

Cancer-associated cachexia (muscle wasting) is less common in breast cancer than in advanced gastrointestinal cancers, but omega-3s may still support muscle maintenance during treatment.

2. Aromatase Inhibitor–Related Joint Pain

Joint pain (arthralgia) is common with aromatase inhibitors such as:

Anastrozole
Letrozole
Exemestane

A randomized clinical trial published in Cancer found that omega-3 supplementation reduced joint pain in obese women taking aromatase inhibitors.

Reference: https://pubmed.ncbi.nlm.nih.gov/26259826/

This suggests omega-3s may be particularly helpful in managing treatment-related inflammation.

Omega-3s and Recurrence Risk

Observational survivorship studies suggest that higher marine omega-3 intake may be associated with:

Lower risk of breast cancer recurrence
Improved overall survival

For example, research from the Nurses’ Health Study found that higher EPA/DHA intake was associated with improved breast cancer–specific survival.

Reference: https://pubmed.ncbi.nlm.nih.gov/24114568/

While observational studies cannot prove causation, the signal is encouraging.

Omega-3s, Inflammation, and the Tumor Microenvironment

Chronic inflammation contributes to tumor progression. Omega-3 fatty acids compete with omega-6 fatty acids in cell membranes and may reduce pro-inflammatory eicosanoid production.

Modern Western diets are often high in omega-6 fatty acids and low in omega-3s, creating a pro-inflammatory ratio. Adjusting this balance through diet may theoretically support anti-cancer physiology.

Potential Cardiovascular Benefits

Many breast cancer survivors receive treatments that may increase cardiovascular risk, including:

Anthracycline chemotherapy
Radiation to the left chest wall
Hormonal therapies

Omega-3s are well established for supporting heart health, reducing triglycerides, and improving endothelial function. Supporting cardiovascular health is especially important in long-term survivorship.

Are Omega-3 Supplements Safe?

In general, omega-3 supplements are well tolerated. Possible side effects include:

Fishy aftertaste
Mild gastrointestinal upset
Increased bleeding risk at very high doses

Most oncology guidelines consider omega-3 supplementation safe at typical doses (1–3 grams/day of combined EPA/DHA). However, patients should always consult their oncologist before starting supplements, especially if:

They are on blood thinners
They have upcoming surgery
They are receiving chemotherapy

Food First: Best Dietary Sources

Rather than relying solely on supplements, many experts recommend dietary sources:

Wild salmon
Sardines
Mackerel
Anchovies
Flaxseed
Chia seeds
Walnuts

General survivorship guidelines often recommend fatty fish at least twice weekly.

Limitations of the Research

It’s important to keep expectations realistic:

Many studies are observational.
Clinical trials are often small.
Effects are modest—not dramatic.
Omega-3s are supportive, not curative.

Omega-3 fatty acids should be viewed as one component of a comprehensive survivorship plan that may include:

Anti-inflammatory diet
Regular physical activity
Weight management
Stress reduction
Evidence-based integrative therapies

Bottom Line

For breast cancer patients and survivors, omega-3 fatty acids may:

Modestly reduce inflammation
Improve joint pain from aromatase inhibitors
Support cardiovascular health
Potentially reduce recurrence risk
Improve treatment tolerance

They are not a standalone treatment—but they appear to be a safe, evidence-supported adjunct to standard breast cancer therapy.

If you are considering omega-3 supplementation during breast cancer treatment, discuss dosing and safety with your oncology team.

Final Thought

In cancer care, small supportive interventions can add up. Nutrition is not a cure, but it is one of the few variables patients can control. Omega-3 fatty acids represent a promising, low-risk strategy that may support both quality of life and long-term survivorship in breast cancer.

Omega-3 Fatty Acids and Breast Cancer Omega-3 Fatty Acids and Breast Cancer Omega-3 Fatty Acids and Breast Cancer